Filter by
Filter by
Prostate Advanced Radiation Technologies Investigating Quality of Life (PARTIQoL): Phase III Randomized Clinical Trial of Proton Therapy vs. IMRT for Localized Prostate Cancer.
PARTIQoL is a multi-center phase 3 randomized trial comparing proton and photon for intermediate- or low-risk prostate cancer with a primary endpoint to compare...
Setting the Stage: Feasibility and Baseline Characteristics in the PARTIQoL Trial Comparing Proton Therapy Versus Intensity Modulated Radiation Therapy for Localized Prostate Cancer.
Published in the Red Journal, this is a report from the PARTIQoL trial focusing on describing the trial design, patient baseline features, clinical details of...
Risk of radiation-induced second malignant neoplasms from photon and proton radiotherapy in paediatric abdominal neuroblastoma
This study compared the carcinogenic risk associated with 3D-CRT, IMAT and PBS-PT)in the treatment of pediatric abdominal neuroblastoma. The risk of radiation...
Trends and variations in utilization and costs of radiotherapy for prostate cancer: A SEER medicare analysis from 2007 through 2016
Based on the SEER database, this study reported that for Medicare beneficiaries with a first-time diagnosis of prostate cancer, the utilization of IMRT, proton...
Cross-modality applicability of rectal normal tissue complication probability models from photon- to proton-based radiotherapy.
This study aimed to assess the applicability of photon-based NTCP models to rectum morbidity outcomes following PT for prostate cancer patients. The data of...
Retrospective analysis of reduced energy switching and room switching times on throughput efficiency of a multi-room proton therapy center.
A 4-room center treating ~90 patients/day, treating for ~7 years underwent a software upgrade which reduced room and energy switching times from ~30 to~20 sec...
Proton beam therapy delivered using pencil beam scanning vs. passive scattering/uniform scanning for localized prostate cancer: Comparative toxicity analysis of PCG 001-09.
This study compared PBS toxicity rates with those of passive scattering/uniform scanning (PS/US) in a prospective multicenter registry. For low-to-intermediate...